Liesbeth focuses on the life sciences sector in the following fields:
patents,
regulatory affairs (MA procedures, pricing-reimbursement, clinical trials, compliance and advertising issues, pharmaco- and materiovigilance, supply chain management etc.),
unfair competition,
privacy and data protection laws.
She advises, litigates, draft contracts and gives trainings on the above matters. She is in frequent contact with the authorities and industry bodies.
Liesbeth has extensive experience in late life-cycle management through regulatory and patent-based actions against early generic entry, provides pre-litigation advice and helps to develop patent portfolio strategies.
Liesbeth’s clients include large research-oriented pharmaceutical, medical device and biotech companies, industry bodies and universities.
Liesbeth also teaches the IP course in the IFB Biotechnology Masterclass, at the Brussels university VUB, is a member of the editorial board of the Belgian magazine IRDI and has published a number of articles in her fields.
Summary paragraph or bullet points
HOYNG MONEGIER is a specialised European intellectual property and regulatory law boutique established on 1 January 2011.
Its core practice consists of IP litigation, contractual and advice work in all its forms and across all sectors. A particular specialty is high-end patent litigation, often played out in parallel in a number of jurisdictions.
HOYNG MONEGIER also services life science client’s needs in terms of regulatory work with advice, contracts and litigation. Its EU and national Life Sciences Regulatory practice is based in Amsterdam and Brussels and has a strong track record in pharmaceutical, biotech and medical devices regulatory matters.
Its practice covers the full range of EU and national regulatory matters as they appear during the life cycle of the product. The team has extensive experience in advising on these matters and is in frequent contact with the EU and national competent authorities and industry bodies. Our lawyers also litigate regulatory matters in the EU courts and across all national courts and industry boards in the member states in cooperation with a trusted network of local counsels.
